Pharmaceuticals in Rivers of Two Regions with Contrasted Socio-Economic Conditions: Occurrence, Accumulation, and Comparison for Ukraine and France

The goal of our study was to identify pharmaceuticals, their potential sources and consumption level in two different socioeconomic and geographical regions—Bordeaux, France and Kharkiv, Ukraine. These substances were monitored in rivers water during contrasted seasonal conditions with application of passive samplers. The 21 pharmaceuticals (psychiatric drugs: alprazolam, amitriptyline, diazepam, fluoxetine, nordiazepam, carbamazepine, bromazepam; analgesics: aspirin, paracetamol; broncholidator: clenbuterol, salbutamol, terbutaline; non-steroidal anti-inflammatory drug: diclofenac, ibuprofen, ketoprofen, naproxen; lipid regulator: gemfibrozil; stimulants: caffeine, theophylline) were identified in sites upstream and downstream of urban areas and discharge of wastewaters. Caffeine, carbamazepine, and diclofenac were relatively abundant into the surface water and could be considered as potential anthropogenic markers of wastewater discharges into rivers. A mass balance modeling has been applied to calculate approximate consumption rates for carbamazepine, diclofenac, and caffeine in both regions to assess socio-economic factors linked with pharmaceuticals behavior.

[1]  Anne Togola,et al.  Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. , 2006, Environmental science & technology.

[2]  Satoshi Takizawa,et al.  Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage. , 2008, Environmental science & technology.

[3]  H. Budzinski,et al.  Development of polar organic integrative samplers for analysis of pharmaceuticals in aquatic systems. , 2007, Analytical chemistry.

[4]  P. Toutain,et al.  Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. , 2004, Journal of veterinary pharmacology and therapeutics.

[5]  Thomas Heberer,et al.  Tracking persistent pharmaceutical residues from municipal sewage to drinking water , 2002 .

[6]  Chris D. Metcalfe,et al.  Sampling in the Great Lakes for pharmaceuticals, personal care products, and endocrine‐disrupting substances using the passive polar organic chemical integrative sampler , 2010, Environmental toxicology and chemistry.

[7]  R. Grabic,et al.  Passive sampling methods for monitoring endocrine disruptors in the Svratka and Svitava rivers in the Czech Republic , 2010, Environmental toxicology and chemistry.

[8]  Annemarie P van Wezel,et al.  Relating environmental concentrations of pharmaceuticals to consumption: A mass balance approach for the river Rhine. , 2010, Environment international.

[9]  Zulin Zhang,et al.  Analysis of emerging contaminants in sewage effluent and river water: comparison between spot and passive sampling. , 2008, Analytica chimica acta.

[10]  Adriano Joss,et al.  Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. , 2006, Water research.

[11]  R. Dinsdale,et al.  Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities. , 2009, Environmental pollution.

[12]  J. Fick,et al.  Strategies for monitoring the emerging polar organic contaminants in water with emphasis on integrative passive sampling. , 2009, Journal of chromatography. A.

[13]  Charles S Wong,et al.  Laboratory calibration and field deployment of the Polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water , 2007, Environmental toxicology and chemistry.

[14]  R. Fanelli,et al.  Illicit drugs, a novel group of environmental contaminants. , 2008, Water research.

[15]  Stuart J Khan,et al.  Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. , 2004, Chemosphere.

[16]  M. Benotti,et al.  Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. , 2007, Environmental science & technology.

[17]  Johnette Shockley,et al.  The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. , 2009, Environmental pollution.

[18]  F. Ventura,et al.  Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. , 2008, The Science of the total environment.

[19]  T. Albanis,et al.  Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. , 2010, Journal of hazardous materials.

[20]  T. Poiger,et al.  Caffeine, an anthropogenic marker for wastewater comtamination of surface waters. , 2003, Environmental science & technology.

[21]  F. Huneau,et al.  Monitoring and flux determination of trace metals in rivers of the Seversky Donets basin (Ukraine) using DGT passive samplers , 2012, Environmental Earth Sciences.

[22]  B. Roig,et al.  Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs? , 2009, Environment international.

[23]  T. J. Leiker,et al.  A holistic passive integrative sampling approach for assessing the presence and potential impacts of waterborne environmental contaminants. , 2004, Chemosphere.

[24]  D. Barceló,et al.  Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain) , 2008 .

[25]  R. Losier,et al.  The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. , 2008, The Science of the total environment.

[26]  A. Togola.  Présence et devenir des substances pharmaceutiques dans les écosystèmes aquatiques , 2006 .

[27]  D. Kolpin,et al.  A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States--I) groundwater. , 2008, The Science of the total environment.

[28]  H. Budzinski,et al.  Passive samplers for chemical substance monitoring and associated toxicity assessment in water. , 2009, Water science and technology : a journal of the International Association on Water Pollution Research.

[29]  P. Stackelberg,et al.  Comparison of a novel passive sampler to standard water-column sampling for organic contaminants associated with wastewater effluents entering a New Jersey stream. , 2005, Chemosphere.

[30]  E. V. C. Rosa,et al.  Tracking Anthropogenic Inputs in Barigui River, Brazil Using Biomarkers , 2010 .

[31]  I. Allan,et al.  Passive sampling techniques for monitoring pollutants in water , 2005 .

[32]  T. Ginn,et al.  Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. , 2005, Journal of hazardous materials.

[33]  J. Cook,et al.  Nonsteroidal antiinflammatory drugs: a review. , 2005, Journal of the American Animal Hospital Association.

[34]  D. Alvarez,et al.  Polar Organic Chemical Integrative Sampling and Liquid Chromatography–Electrospray/Ion-Trap Mass Spectrometry for Assessing Selected Prescription and Illicit Drugs in Treated Sewage Effluents , 2004, Archives of environmental contamination and toxicology.

[35]  H. Kroiss,et al.  Quantification of sewer exfiltration using the anti-epileptic drug carbamazepine as marker species for wastewater. , 2005, Water science and technology : a journal of the International Association on Water Pollution Research.

[36]  D. Kolpin,et al.  Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. , 2005, Environmental science & technology.

[37]  R. Dinsdale,et al.  Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination. , 2009, Environmental pollution.

[38]  M. Cleuvers.  Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. , 2003, Toxicology letters.

[39]  M. Depledge,et al.  Nanomaterials and the environment: The views of the Royal Commission on Environmental Pollution (UK) , 2010, Environmental toxicology and chemistry.

[40]  D. Voutsa,et al.  Passive sampling of selected endocrine disrupting compounds using polar organic chemical integrative samplers. , 2008, Environmental pollution.

[41]  Graham A. Mills,et al.  Strategic monitoring for the European Water Framework Directive , 2006 .

[42]  Hélène Budzinski,et al.  Multi-residue analysis of pharmaceutical compounds in aqueous samples. , 2008, Journal of chromatography. A.

[43]  H. Budzinski,et al.  Analytical development for analysis of pharmaceuticals in water samples by SPE and GC–MS , 2007, Analytical and bioanalytical chemistry.

[44]  N Kreuzinger,et al.  Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. , 2004, Water research.